39 related articles for article (PubMed ID: 17083056)
1. A multinational assessment of complications in type 1 diabetes: the DiaMond substudy of complications (DiaComp) Level 1.
Walsh MG; Zgibor J; Borch-Johnsen K; Orchard TJ
Diab Vasc Dis Res; 2006 47; 3(2):80-83. PubMed ID: 17083056
[TBL] [Abstract][Full Text] [Related]
2. A multinational assessment of complications in type 1 diabetes: the DiaMond substudy of complications (DiaComp) level 1.
Walsh MG; Zgibor J; Borch-Johnsen K; Orchard TJ;
Diab Vasc Dis Res; 2006 Sep; 3(2):84-92. PubMed ID: 17058628
[TBL] [Abstract][Full Text] [Related]
3. A multinational comparison of complications assessment in type 1 diabetes: the DiaMond substudy of complications (DiaComp) level 2.
Walsh MG; Zgibor J; Borch-Johnsen K; Orchard TJ;
Diabetes Care; 2004 Jul; 27(7):1610-7. PubMed ID: 15220236
[TBL] [Abstract][Full Text] [Related]
4. The socioeconomic correlates of global complication prevalence in type 1 diabetes (T1D): a multinational comparison.
Walsh MG; Zgibor J; Songer T; Borch-Johnsen K; Orchard TJ;
Diabetes Res Clin Pract; 2005 Nov; 70(2):143-50. PubMed ID: 16188576
[TBL] [Abstract][Full Text] [Related]
5. [Diabetes self-management and its association with diabetic retinopathy in patients with type 2 diabetes].
Li N; Yang XF; Deng Y; Gu H; Ren XT; Xu J; Ma K; Liu NP
Zhonghua Yan Ke Za Zhi; 2013 Jun; 49(6):500-6. PubMed ID: 24119962
[TBL] [Abstract][Full Text] [Related]
6. Diabetes technology and treatments in the paediatric age group.
Shalitin S; Peter Chase H
Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816
[TBL] [Abstract][Full Text] [Related]
7. Early onset type 2 diabetes mellitus: a harbinger for complications in later years--clinical observation from a secondary care cohort.
Song SH; Hardisty CA
QJM; 2009 Nov; 102(11):799-806. PubMed ID: 19734298
[TBL] [Abstract][Full Text] [Related]
8. Plasma homocysteine and microvascular and macrovascular complications in type 1 diabetes: a cross-sectional nested case-control study.
Soedamah-Muthu SS; Chaturvedi N; Teerlink T; Idzior-Walus B; Fuller JH; Stehouwer CD;
J Intern Med; 2005 Nov; 258(5):450-9. PubMed ID: 16238681
[TBL] [Abstract][Full Text] [Related]
9. [Prevalence of diabetes, antidiabetic treatment and chronic diabetic complications reported by general practitioners].
Fabian W; Majkowska L; Stefański A; Moleda P
Przegl Lek; 2005; 62(4):201-5. PubMed ID: 16229234
[TBL] [Abstract][Full Text] [Related]
10. [Prevalence of chronic diabetes complications depending on the method of insulin therapy in children and adolescents with type 1 diabetes].
Florys B; Ołdytowska A; Głowińska B; Peczyńska J; Urban M
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2004; 10(1):31-9. PubMed ID: 15355737
[TBL] [Abstract][Full Text] [Related]
11. Eye complications and markers of morbidity and mortality in long-term type 1 diabetes.
Grauslund J
Acta Ophthalmol; 2011 Feb; 89 Thesis 1():1-19. PubMed ID: 21443578
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of vascular complications and their risk factors in type 2 diabetes.
Ramachandran A; Snehalatha C; Satyavani K; Latha E; Sasikala R; Vijay V
J Assoc Physicians India; 1999 Dec; 47(12):1152-6. PubMed ID: 11225214
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of diabetic complications in fibrocalculous pancreatic diabetic patients and type 2 diabetic patients: a cross-sectional comparative study.
Kanta Barman K; Padmanabhan M; Premalatha G; Deepa R; Rema M; Mohan V
J Diabetes Complications; 2004; 18(5):264-70. PubMed ID: 15337499
[TBL] [Abstract][Full Text] [Related]
14. Thailand diabetes registry project: prevalence of vascular complications in long-standing type 2 diabetes.
Leelawattana R; Pratipanawatr T; Bunnag P; Kosachunhanun N; Suwanwalaikorn S; Krittiyawong S; Chetthakul T; Plengvidhya N; Benjasuratwong Y; Deerochanawong C; Mongkolsomlit S; Ngarmukos C; Rawdaree P
J Med Assoc Thai; 2006 Aug; 89 Suppl 1():S54-9. PubMed ID: 17717878
[TBL] [Abstract][Full Text] [Related]
15. The onset of NIDDM and its relationship to clinical diagnosis in Egyptian adults.
Thompson TJ; Engelgau MM; Hegazy M; Ali MA; Sous ES; Badran A; Herman WH
Diabet Med; 1996 Apr; 13(4):337-40. PubMed ID: 9162609
[TBL] [Abstract][Full Text] [Related]
16. A study of diabetes complications in an endogamous population: an emerging public health burden.
Bener A; Al-Laftah F; Al-Hamaq AO; Daghash M; Abdullatef WK
Diabetes Metab Syndr; 2014; 8(2):108-14. PubMed ID: 24907176
[TBL] [Abstract][Full Text] [Related]
17. Does osteoprotegerin relate to micro- and macrovascular complications in long-term type 1 diabetes?
Grauslund J; Rasmussen LM; Green A; Sjølie AK
Scand J Clin Lab Invest; 2010 Apr; 70(3):188-93. PubMed ID: 20205614
[TBL] [Abstract][Full Text] [Related]
18. The geoepidemiology of type 1 diabetes.
Borchers AT; Uibo R; Gershwin ME
Autoimmun Rev; 2010 Mar; 9(5):A355-65. PubMed ID: 19969107
[TBL] [Abstract][Full Text] [Related]
19. Incidence of coronary heart disease in type 2 diabetic men and women: impact of microvascular complications, treatment, and geographic location.
Avogaro A; Giorda C; Maggini M; Mannucci E; Raschetti R; Lombardo F; Spila-Alegiani S; Turco S; Velussi M; Ferrannini E;
Diabetes Care; 2007 May; 30(5):1241-7. PubMed ID: 17290034
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of chronic complications, metabolic control and nutritional intake in type 1 diabetes: comparison between different European regions. EURODIAB Complications Study group.
Toeller M; Buyken AE; Heitkamp G; Berg G; Scherbaum WA
Horm Metab Res; 1999 Dec; 31(12):680-5. PubMed ID: 10668922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
